Dr. Wardrop’s research focuses on developing methods for target-directed organic synthesis and their application to the synthesis of bioactive natural products and drug discovery. Work in the Wardrop group is currently focused on epigenetic-based immunotherapy agents and the development of ultra-selective HDAC6 inhibitors treatment of melanoma and other malignancies.
![Photo of Duncan Wardrop, PhD](https://cancer.uillinois.edu/wp-content/uploads/2023/05/Wardrop-Duncan-300x300-1.jpg)
Duncan Wardrop, PhD
Associate Professor
Department of Chemistry
College of Liberal Arts and Sciences
Research Program
Cancer Biology (CB)
Phone: (312) 485-9529
Email: [email protected]